The mean percentage of SP cells from ascites derived from human ovarian cancer patients, ascites from mice inoculated with OVCAR3, and A2780-CP cell lines were 0.4±0.05%, 1.01±0.27%, and 0.45±0.05%, respectively. This evidence concerns the gene CP and ovarian carcinoma.